Drug combination shuts down cancer stem cells and tumor growth in aggressive lung cancer

(Mayo Clinic) Researchers on Mayo Clinic's Florida campus have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent.